Loading…

Adenosine 3',5'-Monophosphate as the Intracellular Mediator of the Action of Adrenocorticotropic Hormone on the Adrenal Cortex

Several pieces of evidence have been established which indicate that adenosine 3',5'-monophosphate is the intracellular mediator of the action of adrenocorticotropic hormone (ACTH) on the adrenal cortex. 1. Increases in adrenal cyclic AMP concentrations induced by ACTH occurred before incr...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of biological chemistry 1967-12, Vol.242 (23), p.5535-5541
Main Authors: Grahame-Smith, D G, Butcher, R W, Ney, R L, Sutherland, E W
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Several pieces of evidence have been established which indicate that adenosine 3',5'-monophosphate is the intracellular mediator of the action of adrenocorticotropic hormone (ACTH) on the adrenal cortex. 1. Increases in adrenal cyclic AMP concentrations induced by ACTH occurred before increases in the rate of adrenal steroidogenesis. 2. Increasing doses of ACTH produced increasing concentrations of adrenal cyclic AMP as steroidogenesis was progressively stimulated, and adrenal concentrations of cyclic AMP remained elevated while the rate of steroidogenesis was maintained. 3. The potency of analogues of ACTH in producing stimulation of adrenal steroidogenesis was reflected in their potency in producing increases in adrenal cyclic AMP concentration. 4. ACTH increased cyclic AMP levels not only in adrenal quarters in vitro and in intact adrenals in vivo but also in adrenal homogenates under conditions which suggested that ACTH was acting to increase adenyl cyclase activity. In addition, cycloheximide, an inhibitor of protein synthesis, although known to inhibit the steroidogenic effects of ACTH or exogenous cyclic AMP did not antagonize the increase in cyclic AMP concentration induced by ACTH. Thus, cycloheximide and, by inference, the newly synthesized protein thought to be involved in steroidogenesis would appear to act at a site past adenyl cyclase. NADPH, which stimulates steroidogenesis but is not antagonized by cycloheximide, had no effect on cyclic AMP levels. This suggests that NADPH acts either at a point distal to both the mechanism producing increased cyclic AMP and past that at which inhibitors of protein synthesis interfere with the reactions leading to stimulation of steroidogenesis, or by a different mechanism. Finally, at a time after hypophysectomy when adrenal weight had fallen and the acute adrenal steroidogenic response to ACTH had disappeared, the sensitivity of the adrenal cyclic AMP response to ACTH was undiminished. The ability of the atropic adrenal to accumulate cyclic AMP in response to ACTH was compatible with the hypothesis that cyclic AMP is involved in the mechanism for the restitution of adrenal growth and steroidogenic capacity.
ISSN:0021-9258
1083-351X
DOI:10.1016/s0021-9258(18)99390-7